Dudediligence.

Veracyte, Inc

VCYTNASDAQ · Services-Medical Laboratories
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$19.8M

31 notices · 450,691 sh

Oct 2025 to Oct 2026

Reported ·

$19.7M

48 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

45 of 48 reported sales carry the 10b5-1 box. Together they are 0.55% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-24: JENS HOLSTEIN, Form 1442026-09-21: JOHN LEITE, Form 1442026-09-14: JENS HOLSTEIN, Form 1442026-09-04: ANN MCGUIRE, Form 1442026-09-04: REBECCA CHAMBERS, Form 1442026-09-04: PHILLIP FEBBO, Form 1442026-09-01: MUNA BHANJI, Form 1442026-06-18: KARIN EASTHAM, Form 1442026-06-04: ANN MCGUIRE, Form 1442026-06-04: John Leite, Form 1442026-06-04: MARC STAPLEY, Form 1442026-06-04: REBECCA CHAMBERS, Form 1442026-05-20: ROBERT EPSTEIN, Form 1442026-05-06: ANN MCGUIRE, Form 1442026-03-04: ANN MCGUIRE, Form 1442026-03-04: John Leite, Form 1442026-03-04: REBECCA CHAMBERS, Form 1442026-03-04: MARC STAPLEY, Form 1442026-03-02: PHILLIP FEBBO, Form 1442025-12-16: ANN MCGUIRE, Form 1442025-12-05: KARIN EASTHAM, Form 1442025-12-04: ANN MCGUIRE, Form 1442025-12-04: REBECCA CHAMBERS, Form 1442025-12-04: MARC STAPLEY, Form 1442025-11-25: Evan Jones, Form 1442025-11-25: John Leite, Form 1442025-11-20: JENS HOLSTEIN, Form 1442025-11-05: Evan Jones, Form 1442025-11-05: KARIN EASTHAM, Form 1442025-11-05: ANN MCGUIRE, Form 1442025-11-05: REBECCA CHAMBERS, Form 1442025-11-05: JONES EVAN/ FA, sold2025-11-05: EASTHAM KARIN, sold2025-11-05: Chambers Rebecca, sold2025-11-05: McGuire Annie, sold2025-11-07: Wygant Jonathan, sold2025-11-20: Holstein Jens, sold2025-11-25: JONES EVAN/ FA, sold2025-11-25: Leite John, sold2025-12-04: Stapley Marc, sold2025-12-04: Chambers Rebecca, sold2025-12-04: McGuire Annie, sold2025-12-04: Leite John, sold2025-12-05: EASTHAM KARIN, sold2025-12-16: McGuire Annie, sold2026-03-02: Febbo Phillip G., sold2026-03-04: Stapley Marc, sold2026-03-04: Chambers Rebecca, sold2026-03-04: McGuire Annie, sold2026-03-04: Leite John, sold2026-05-06: McGuire Annie, sold2026-05-20: EPSTEIN ROBERT S, sold2026-05-22: Wygant Jonathan, sold2026-06-04: Stapley Marc, sold2026-06-04: Chambers Rebecca, sold2026-06-04: McGuire Annie, sold2026-06-04: Leite John, sold2026-06-18: EASTHAM KARIN, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-24JENS HOLSTEIN, Director$352,500
7,500 shplan 2026-06-12Form 4s on file end Jun 23144 ↗
2026-09-21JOHN LEITE, Global Chief Commercial Off$159,777
4,015 shplan 2026-06-09Form 4s on file end Jun 23144 ↗
2026-09-14JENS HOLSTEIN, Director$204,747
5,000 shplan 2026-06-12Form 4s on file end Jun 23144 ↗
2026-09-04ANN MCGUIRE, EVP, General Counsel$145,356
3,254 shplan 2025-08-29Form 4s on file end Jun 23144 ↗
2026-09-04REBECCA CHAMBERS, Chief Financial Officer$163,135
3,652 shplan 2025-08-21Form 4s on file end Jun 23144 ↗
2026-09-04PHILLIP FEBBO, Chief Scientific & Med Officer$585,624
13,110 shplan 2025-08-21Form 4s on file end Jun 23144 ↗
2026-09-01MUNA BHANJI, Director$161,012
3,728 shplan 2026-06-02Form 4s on file end Jun 23144 ↗
2026-06-18KARIN EASTHAM, Director$191,260
3,729 shplan 2025-09-05144 ↗
Form 4, 2026-06-22: sold 3,729 at $52.89 Form 4 ↗
2026-06-04ANN MCGUIRE, EVP, General Counsel$154,639
3,176 shplan 2025-08-29144 ↗
Form 4, 2026-06-04: sold 3,176 at $49.76 Form 4 ↗
2026-06-04John Leite, Global Chief Commercial Off$680,443
13,975 shplan 2025-06-09144 ↗
Form 4, 2026-06-04: sold 13,975 at $50.07 Form 4 ↗
2026-06-04MARC STAPLEY, Chief Executive Officer$6,721,703
138,051 shplan 2025-11-24144 ↗
Form 4, 2026-06-04: sold 138,051 at $50.12 Form 4 ↗
2026-06-04REBECCA CHAMBERS, Chief Financial Officer$173,385
3,561 shplan 2025-08-21144 ↗
Form 4, 2026-06-04: sold 3,561 at $49.73 Form 4 ↗
2026-05-20ROBERT EPSTEIN, Director$416,900
10,000 shplan 2025-12-05144 ↗
Form 4, 2026-05-22: sold 10,000 at $44.01 Form 4 ↗
2026-05-06ANN MCGUIRE, EVP, General Counsel$336,426
10,204 shplan 2025-08-29144 ↗
Form 4, 2026-05-08: sold 10,204 at $39.02 Form 4 ↗
2026-03-04ANN MCGUIRE, EVP, General Counsel$233,563
6,658 shplan 2025-08-29144 ↗
Form 4, 2026-03-06: sold 6,658 at $35.55 Form 4 ↗
2026-03-04John Leite, Global Chief Commercial Off$184,521
5,260 shplan 2025-06-09144 ↗
Form 4, 2026-03-06: sold 5,260 at $35.19 Form 4 ↗
2026-03-04REBECCA CHAMBERS, Chief Financial Officer$643,402
18,341 shplan 2025-08-21144 ↗
Form 4, 2026-03-06: sold 18,341 at $36.14 Form 4 ↗
2026-03-04MARC STAPLEY, Chief Executive Officer$1,596,947
45,523 shplan 2025-11-24144 ↗
Form 4, 2026-03-06: sold 45,523 at $35.98 Form 4 ↗
2026-03-02PHILLIP FEBBO, Chief Scientific & Med Officer$491,221
13,425 shplan 2025-08-21144 ↗
Form 4, 2026-03-04: sold 13,425 at $36.16 Form 4 ↗
2025-12-16ANN MCGUIRE, EVP, General Counsel$467,469
10,739 shplan 2025-08-29144 ↗
Form 4, 2025-12-17: sold 10,739 at $43.14 Form 4 ↗
2025-12-05KARIN EASTHAM, Director$948,200
20,000 shplan 2025-09-05144 ↗
Form 4, 2025-12-08: sold 20,000 at $45.45 Form 4 ↗
2025-12-04ANN MCGUIRE, EVP, General Counsel$67,901
1,422 shplan 2024-09-04144 ↗
Form 4, 2025-12-04: sold 1,422 at $47.30 Form 4 ↗
2025-12-04REBECCA CHAMBERS, Chief Financial Officer$634,025
13,278 shplan 2025-08-21144 ↗
Form 4, 2025-12-04: sold 13,278 at $46.84 Form 4 ↗
2025-12-04MARC STAPLEY, Chief Executive Officer$366,147
7,668 shplan 2024-09-13144 ↗
Form 4, 2025-12-04: sold 7,668 at $47.09 Form 4 ↗
2025-11-25Evan Jones, Director$246,900
5,000 shplan 2024-12-09144 ↗
Form 4, 2025-11-26: sold 1,106 at $50.25 Form 4 ↗
2025-11-25John Leite, Global Chief Commercial Off$190,816
4,086 shplan 2025-06-09144 ↗
Form 4, 2025-11-26: sold 2,808 at $50.00 Form 4 ↗
2025-11-20JENS HOLSTEIN, Director$423,563
10,000 shplan 2025-08-21144 ↗
Form 4, 2025-11-21: sold 10,000 at $42.36 Form 4 ↗
2025-11-05Evan Jones, Director$1,988,744
43,196 shplan 2024-12-09144 ↗
Form 4, 2025-11-07: sold 43,196 at $45.06 Form 4 ↗
2025-11-05KARIN EASTHAM, Director$349,425
9,674 shplan 2024-08-20144 ↗
Form 4, 2025-11-07: sold 9,674 at $40.02 Form 4 ↗
2025-11-05ANN MCGUIRE, EVP, General Counsel$233,552
6,466 shplan 2024-09-04144 ↗
Form 4, 2025-11-07: sold 6,466 at $40.00 Form 4 ↗
2025-11-05REBECCA CHAMBERS, Chief Financial Officer$252,840
7,000 shplan 2024-08-13144 ↗
Form 4, 2025-11-07: sold 7,000 at $41.00 Form 4 ↗